These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Montalvo EA; Grose C Virology; 1986 Mar; 149(2):230-41. PubMed ID: 2418586 [TBL] [Abstract][Full Text] [Related]
25. Serological reactivity of some monoclonal antibodies to varicella-zoster virus. Forghani B; Schmidt NJ; Myoraku CK; Gallo D Arch Virol; 1982; 73(3-4):311-7. PubMed ID: 6184037 [TBL] [Abstract][Full Text] [Related]
26. Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay. Liu J; Ye X; Jia J; Zhu R; Wang L; Chen C; Yang L; Wang Y; Wang W; Ye J; Li Y; Zhu H; Zhao Q; Cheng T; Xia N Sci Rep; 2016 Feb; 6():20577. PubMed ID: 26853741 [TBL] [Abstract][Full Text] [Related]
27. The serological relationship of varicella-zoster virus to other primate herpesviruses. Harbour DA; Caunt AE J Gen Virol; 1979 Nov; 45(2):469-77. PubMed ID: 232132 [TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Grose C; Edwards DP; Friedrichs WE; Weigle KA; McGuire WL Infect Immun; 1983 Apr; 40(1):381-8. PubMed ID: 6299963 [TBL] [Abstract][Full Text] [Related]
29. Generation of hybridomas producing human monoclonal antibodies against herpes simplex virus after in vitro stimulation. Masuho Y; Sugano T; Matsumoto Y; Sawada S; Tomibe K Biochem Biophys Res Commun; 1986 Mar; 135(2):495-500. PubMed ID: 3008724 [TBL] [Abstract][Full Text] [Related]
30. Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus. Massaer M; Haumont M; Place M; Bollen A; Jacobs P J Gen Virol; 1993 Mar; 74 ( Pt 3)():491-4. PubMed ID: 8383181 [TBL] [Abstract][Full Text] [Related]
31. Recognition of similar epitopes on varicella-zoster virus gpI and gpIV by monoclonal antibodies. Vafai A; Wroblewska Z; Mahalingam R; Cabirac G; Wellish M; Cisco M; Gilden D J Virol; 1988 Aug; 62(8):2544-51. PubMed ID: 2455814 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of varicella-zoster virus (VZV) glycoprotein expression by a human monoclonal antibody against VZV glycoprotein III. Ito M; Mizutani K; Kamiya T; Ihara T; Kamiya H; Sakurai M; Sugano T; Matumoto Y J Infect Dis; 1993 Nov; 168(5):1256-9. PubMed ID: 8228360 [TBL] [Abstract][Full Text] [Related]
33. Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140). Montalvo EA; Grose C J Virol; 1987 Sep; 61(9):2877-84. PubMed ID: 3039175 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens. Okuno T; Yamanishi K; Shiraki K; Takahashi M Virology; 1983 Sep; 129(2):357-68. PubMed ID: 6312679 [TBL] [Abstract][Full Text] [Related]
35. Rapid diagnosis of varicella-zoster virus infection with a monoclonal antibody based direct immunofluorescence technique. Rawlinson WD; Dwyer DE; Gibbons VL; Cunningham AL J Virol Methods; 1989 Jan; 23(1):13-8. PubMed ID: 2536379 [TBL] [Abstract][Full Text] [Related]